ST LOUIS, Mo.–(EON: Enhanced Online News)–Tripos®, a leading provider of drug discovery informatics products and services, today announced that a top 15 global pharmaceutical company has licensed D360 as its enterprise solution for scientific data integration and data mining, visualization, and analysis.

D360 is used by scientists to access multiple types of data, including chemical, biological, PK/PD data and more, regardless of database location and architecture. D360’s integrated analysis and visualization tools mean that scientists can quickly and easily get a view of their data, and perform analyses that accelerate scientific understanding, in just a few mouse clicks, without having to learn multiple applications. With D360, users can easily present and share complex research data and their findings in a format conducive to their research tasks, leading to streamlined project team collaboration and better informed decisions all through a self-supporting user community that requires little IT support. Additionally, the generation of data views, complete with analyses, can be automated for regular tasks, further streamlining scientists’ workflows.

“More and more pharma, biotech, and related research teams are now looking for improved data integration, data mining and analysis solutions to streamline their workflows and focus on science and innovation. D360 is the premier product for this essential need and demonstrates proven performance, scalability and cost effectiveness to be deployed at any size pharmaceutical or biotech organization to improve research effectiveness by allowing easy access to rational data-driven decision making,” said James Hayden, Senior Vice President of Sales and Marketing for Tripos. “Additionally, very low ongoing maintenance overhead makes D360 the most cost effective solution on the market for any size life science organization.”

More information about D360’s data integration, data mining, visualization and analysis capabilities can be found at the Tripos web site.

About Tripos

Tripos, a Certara™ Company, is a global leader in innovative scientific solutions enabling life science researchers to improve the efficiency of molecular discovery. Established in 1979, Tripos was the first company to bring scientific computational drug discovery capabilities to the pharmaceutical, chemical, food and fragrance industries, and today helps a broad range of companies and research facilities accelerate the identification and optimization of new compounds intended to become tomorrow’s drugs, foods, flavorings and fragrances.

About Certara

Certara unites Tripos (www.tripos.com) and Pharsight Corporation (www.pharsight.com), and is dedicated to improving human health through a broad spectrum of software products and services, from molecular discovery through clinical research, with special focus on supporting translational approaches to drug development. Pharsight provides software and scientific services to improve productivity and decision-making in clinical drug development.